Ruth Adams
Technik-/Wissenschafts-/F&E-Leiter bei NUVALENT, INC.
Aktive Positionen von Ruth Adams
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NUVALENT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2020 | - |
Karriereverlauf von Ruth Adams
Ehemalige bekannte Positionen von Ruth Adams
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Ruth Adams
| The University of Southampton | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUVALENT, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Ruth Adams
- Erfahrung
